MarketWire Markets · Technology · Signal
X4A MARKETWIRE

Viromed Medical AG advances product development and market launch in the first half of …

X4A MarketWire
$DE.VME

Viromed Medical AG advances product development and market launch in the first half of 2026 and confirms full-year guidance | $DE.VME

CHART
$DE.VME XETR · EQUITY · EUR
Range 1 month
Chart loads when visible

Market data displayed by TradingView. Market data may be delayed.

SOURCE

Original Source

WebDisclosure
Viromed Medical AG |
Viromed Medical AG advances product development and market launch, confirms full-year guidance in its half-year report for 2026. Strategic partnerships and acquisitions enhance growth prospects
www.webdisclosure.com
Read Original Source ↗
SHARE

Share X4A MarketWire

RELATED
Viromed Medical AG Successfully Completes Capital Increase | $DE.VME Viromed Medical AG resolves to conduct a capital increase through a cash contribution, … HSV welcomes Viromed Medical GmbH as a new youth development partner Viromed Medical AG: Study on cold plasma application in the lung accepted for publicati…